{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:20:42Z","timestamp":1793956842167,"version":"4.8.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T00:00:00Z","timestamp":1593216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"\u2018Cariplo Foundation\u2019"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Four clinical phenotypes of IgG4-related disease (IgG4-RD) have been recently identified by latent class analysis (LCA): pancreato-biliary (group 1); retroperitoneum\/aortitis (group 2); head and neck limited (group 3); and Mikulicz\/systemic (group 4). The reproducibility of this classification in clinical practice and its relevance for patient management, however, remain unknown.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The study included 179 patients. Four IgG4-RD experts were asked to classify a validation cohort of 40 patients according to published LCA-derived phenotypes based on clinical judgement. Agreement between LCA and clinical clustering was calculated. To assess differences among disease phenotypes, the following variables were recorded on an additional 139 patients: serum IgG4 and IgE; inflammatory markers; eosinophils; plasmablasts; IgG4-RD responder index (RI); history of atopy, diabetes, osteoporosis, relapses and malignancy; cumulative dose of glucocorticoids; and use of rituximab.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Clinical judgement replicated LCA classification with strong agreement among IgG4-RD experts (\u03ba\u2009=\u20090.841, P\u2009&amp;lt;\u20090.0005). At disease onset, group 1 showed the highest levels of serum IgG4 and IgE. Groups 2 and 4 had the lowest and highest IgG4-RD RI, respectively. At 2 years\u2019 follow-up, group 3 received the highest cumulative dose of glucocorticoids, but higher incidences of diabetes mellitus were observed in groups 1 and 4, consistent with the higher likelihood of pancreatic involvement in groups 1 and 4. No difference among the four groups was observed in terms of disease recurrence, time to relapse and frequency of rituximab infusion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Clinical phenotypes of IgG4-RD reflect differences in epidemiological features and prognostic outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa221","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T21:59:51Z","timestamp":1586296791000},"page":"2435-2442","source":"Crossref","is-referenced-by-count":82,"title":["Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes"],"prefix":"10.1093","volume":"59","author":[{"given":"Marco","family":"Lanzillotta","sequence":"first","affiliation":[{"name":"Universit\u00e0 Vita-Salute San Raffaele, IRCCS San Raffaele Scientific Institute"},{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6806-3794","authenticated-orcid":false,"given":"Corrado","family":"Campochiaro","sequence":"additional","affiliation":[{"name":"Universit\u00e0 Vita-Salute San Raffaele, IRCCS San Raffaele Scientific Institute"},{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Mancuso","sequence":"additional","affiliation":[{"name":"Universit\u00e0 Vita-Salute San Raffaele, IRCCS San Raffaele Scientific Institute"},{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2889-366X","authenticated-orcid":false,"given":"Giuseppe Alvise","family":"Ramirez","sequence":"additional","affiliation":[{"name":"Universit\u00e0 Vita-Salute San Raffaele, IRCCS San Raffaele Scientific Institute"},{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Capurso","sequence":"additional","affiliation":[{"name":"Universit\u00e0 Vita-Salute San Raffaele, IRCCS San Raffaele Scientific Institute"},{"name":"Pancreato-Biliary Endoscopy and Endosonography Division, IRCCS San Raffaele Scientific Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Falconi","sequence":"additional","affiliation":[{"name":"Universit\u00e0 Vita-Salute San Raffaele, IRCCS San Raffaele Scientific Institute"},{"name":"Division of Pancreatic Surgery, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Dagna","sequence":"additional","affiliation":[{"name":"Universit\u00e0 Vita-Salute San Raffaele, IRCCS San Raffaele Scientific Institute"},{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Della-Torre","sequence":"additional","affiliation":[{"name":"Universit\u00e0 Vita-Salute San Raffaele, IRCCS San Raffaele Scientific Institute"},{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,27]]},"reference":[{"key":"2020082700373303900_keaa221-B1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/03009742.2015.1055796","article-title":"IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients","volume":"45","author":"Campochiaro","year":"2016","journal-title":"Scand J Rheumatol"},{"key":"2020082700373303900_keaa221-B2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s10875-016-0331-0","article-title":"\u201cHow I manage\u201d IgG4-related disease","volume":"36","author":"Della-Torre","year":"2016","journal-title":"J Clin Immunol"},{"key":"2020082700373303900_keaa221-B3","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/rheumatology\/kex234","article-title":"Quantitative measurement of 18F-FDG PET\/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease","volume":"56","author":"Berti","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2020082700373303900_keaa221-B4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/apm.12845","article-title":"IgG4-related disease: review of the histopathologic features, differential diagnosis, and therapeutic approach","volume":"126","author":"Bledsoe","year":"2018","journal-title":"APMIS"},{"key":"2020082700373303900_keaa221-B5","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ijom.2019.01.006","article-title":"Clinical features and mechanistic insights regarding IgG4-related dacryoadenitis and sialoadenitis: a review","volume":"48","author":"Maehara","year":"2019","journal-title":"Int J Oral Maxillofac Surg"},{"key":"2020082700373303900_keaa221-B6","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/annrheumdis-2014-205187","article-title":"IgG4-related midline destructive lesion","volume":"73","author":"Della-Torre","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2020082700373303900_keaa221-B7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/14397595.2018.1554321","article-title":"IgG4-related kidney disease and retroperitoneal fibrosis: an update","volume":"29","author":"Kawano","year":"2019","journal-title":"Mod Rheumatol"},{"key":"2020082700373303900_keaa221-B8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.semarthrit.2019.05.003","article-title":"Clinical presentation, treatment and outcome of IgG4-related pachymeningitis: from a national case registry and literature review","volume":"49","author":"Melenotte","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2020082700373303900_keaa221-B9","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/art.40469","article-title":"A CD8\u03b1\u2212 Subset of CD4+SLAMF7+ cytotoxic T cells is expanded in patients with IgG4-related disease and decreases following glucocorticoid treatment","volume":"70","author":"Della-Torre","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2020082700373303900_keaa221-B10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11739-016-1599-z","article-title":"Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease","volume":"12","author":"Rossi","year":"2017","journal-title":"Intern Emerg Med"},{"key":"2020082700373303900_keaa221-B11","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jaci.2019.07.004","article-title":"B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease","volume":"145","author":"Della-Torre","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2020082700373303900_keaa221-B12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","article-title":"Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts","volume":"78","author":"Wallace","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2020082700373303900_keaa221-B13","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"2020082700373303900_keaa221-B14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"key":"2020082700373303900_keaa221-B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pan.2016.12.003","article-title":"International consensus for the treatment of autoimmune pancreatitis","volume":"17","author":"Okazaki","year":"2017","journal-title":"Pancreatology"},{"key":"2020082700373303900_keaa221-B16","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1034\/j.1398-9995.2001.t01-1-00001.x","article-title":"A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force","volume":"56","author":"Johansson","year":"2001","journal-title":"Allergy"},{"key":"2020082700373303900_keaa221-B17","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/acr.23543","article-title":"An international multispecialty validation study of the IgG4-related disease responder index","volume":"70","author":"Wallace","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2020082700373303900_keaa221-B18","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"2020082700373303900_keaa221-B19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"2020082700373303900_keaa221-B20","first-page":"1","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group","volume":"843","year":"1994","journal-title":"World Health Organ Tech Rep Ser"},{"key":"2020082700373303900_keaa221-B21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism Classification criteria for IgG4-related disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2020082700373303900_keaa221-B22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease","volume":"79","author":"Wallace","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2020082700373303900_keaa221-B23","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/annrheumdis-2016-209794","article-title":"Rheumatoid arthritis phenotype at presentation differs depending on the number of autoantibodies present","volume":"76","author":"Derksen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2020082700373303900_keaa221-B24","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/annrheumdis-2012-201750","article-title":"Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis","volume":"72","author":"Mahr","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2020082700373303900_keaa221-B25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/09114300.2018.1451613","article-title":"Predicting therapeutic response in IgG4-related disease based on cluster analysis","volume":"41","author":"Yamamoto","year":"2018","journal-title":"Immunol Med"},{"key":"2020082700373303900_keaa221-B26","article-title":"Urgent manifestations of IgG4-Related Disease","author":"Della-Torre","journal-title":"Scand J Rheumatol."},{"key":"2020082700373303900_keaa221-B27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/all.12342","article-title":"Circulating Th2 memory cells in IgG4-related disease are restricted to a defined subset of subjects with atopy","volume":"69","author":"Mattoo","year":"2014","journal-title":"Allergy"},{"key":"2020082700373303900_keaa221-B28","doi-asserted-by":"crossref","first-page":"831","DOI":"10.14309\/ajg.0000000000000232","article-title":"Methotrexate as induction of remission therapy for type 1 autoimmune pancreatitis","volume":"114","author":"Rovati","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"2020082700373303900_keaa221-B29","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.cgh.2017.02.007","article-title":"Increases in IgE, eosinophils, and mast cells can be used in diagnosis and to predict relapse of IgG4-related disease","volume":"15","author":"Culver","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2020082700373303900_keaa221-B30","first-page":"159","article-title":"Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease","volume":"37","author":"Lanzillotta","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2020082700373303900_keaa221-B31","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/rheumatology\/kev438","article-title":"Predictors of disease relapse in IgG4-related disease following rituximab","volume":"55","author":"Wallace","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2020082700373303900_keaa221-B32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13075-018-1718-5","article-title":"Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse","volume":"20","author":"Lanzillotta","year":"2018","journal-title":"Arthritis Res Ther"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/9\/2435\/33686427\/keaa221.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/9\/2435\/33686427\/keaa221.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T04:38:12Z","timestamp":1598503092000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/9\/2435\/5863688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,27]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,6,27]]},"published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa221","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2020,6,27]]}}}